EGO SUNSENSE MOISTURISING FACE

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

octyl salicylate, Quantity: 50 mg/g; bemotrizinol, Quantity: 20 mg/g; methylene bis-benzotriazolyl tetramethylbutylphenol, Quantity: 25 mg/g

Disponible desde:

Ego Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

Bemotrizinol,methylene bis-benzotriazolyl tetramethylbutylphenol,octyl salicylate

formulario farmacéutico:

Lotion

Composición:

Excipient Ingredients: decyl glucoside; nicotinamide; isopropyl palmitate; aluminium magnesium silicate; mixed (low-alpha type) tocopherols concentrate; glycerol; potassium cetyl phosphate; xanthan gum; purified water; citric acid; diisopropyl adipate; sodium propyl hydroxybenzoate; alkyl (C12-15) benzoate; carbomer 934P; sodium methyl hydroxybenzoate; propylene glycol; glyceryl monostearate; PEG-100 stearate

Vía de administración:

Topical

indicaciones terapéuticas:

May assist in preventing some skin cancers (sunscreen) ; May reduce the risk of some skin cancers (sunscreen) ; SPF 50 PLUS Broad spectrum very high protection sunscreen ; Can aid in the prevention of premature skin ageing (sunscreen) ; Can aid in the prevention of solar keratosis (sunscreen) ; Can aid in the prevention of sunspots (sunscreen)

Resumen del producto:

Visual Identification: ;

Estado de Autorización:

Licence status A

Fecha de autorización:

2011-12-22